Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study
Annals of Surgical Treatment and Research
;
: 36-42, 2016.
Artigo
em Inglês
| WPRIM
| ID: wpr-59525
ABSTRACT
PURPOSE:
HCV-related liver disease is the most common indication for liver transplantation (LT) in Western countries, whereas HCV LT is rare in Korea. We conducted a survey of HCV RNA-positive patients who underwent LT and investigated the prognostic factors for patient survival and the effects of immunosuppression.METHODS:
We retrospectively reviewed the multicenter records of 192 HCV RNA-positive patients who underwent LT.RESULTS:
The 1-, 3-, and 5-year overall survival rates were 78.8%, 75.3%, and 73.1%, respectively. Excluding the cases of hospital mortality (n = 23), 169 patients were evaluated for patient survival. Most patients were genotype 1 (n = 111, 65.7%) or genotype 2 (n = 42, 24.9%). The proportion of living donors for LT (n = 135, 79.9%) was higher than that of deceased donors (deceased donor liver transplantation [DDLT], n = 34, 20.1%). The median donor and recipient ages were 32 years and 56 years, respectively. Twenty-eight patients (16.6%) died during the observation period. Seventy-five patients underwent universal prophylaxis and 15 received preemptive therapy. HCV recurrence was detected in 97 patients. Recipients who were older than 60, received DDLT, used cyclosporine, or suffered acute rejection had lower rates of survival.CONCLUSION:
Patent survival rates of HCV patients after LT in Korea were comparable with other countries.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Recidiva
/
Doadores de Tecidos
/
Taxa de Sobrevida
/
Estudos Retrospectivos
/
Terapia de Imunossupressão
/
Transplante de Fígado
/
Mortalidade Hospitalar
/
Tacrolimo
/
Ciclosporina
/
Hepacivirus
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Annals of Surgical Treatment and Research
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS